Heavy metal ion-induced insulin-mimetic signaling

Anna Eckers1, Lars-Oliver Klotz

  • 1Institut für umweltmedizinische Forschung an der Heinrich-Heine-Universität Düsseldorf (IUF), Düsseldorf, Germany.

Insights

Transition metal ions like copper activate the PI3K/Akt pathway, influencing fuel metabolism and stress responses. This activation involves reactive oxygen species and affects transcription factors like FoxO.

Area of Science:

  • Cellular signaling
  • Metabolic regulation
  • Toxicology

Background:

  • The serine/threonine kinase Akt regulates fuel metabolism and insulin effects.
  • Akt activation is linked to stressful stimuli, including reactive oxygen species (ROS) and heavy metal ions.

Purpose of the Study:

  • To review the activation of the PI3K/Akt signaling cascade by transition metal ions.
  • To discuss mechanisms of Akt activation, the role of ROS, and downstream consequences.

Main Methods:

  • Literature review of studies on PI3K/Akt signaling.
  • Analysis of transition metal ion effects (Cu(II), Zn(II), Ni(II)) on cellular pathways.

Main Results:

  • Transition metal ions activate the PI3K/Akt pathway in a ROS-dependent manner.
  • Akt activation by metals modulates FoxO transcription factors.

Conclusions:

  • Metal-induced Akt activation impacts cellular processes like stress-induced senescence and selenium homeostasis.
  • Understanding these pathways is crucial for metabolic and stress response research.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...